| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 80.57 mm | 80.57 mm | 80.57 mm | 80.57 mm | 80.57 mm | 80.57 mm |
| Cash burn (monthly) | 25.92 mm | 4.47 mm | 13.15 mm | 10.97 mm | 10.67 mm | 8.79 mm |
| Cash used (since last report) | 110.39 mm | 19.03 mm | 55.99 mm | 46.70 mm | 45.45 mm | 37.43 mm |
| Cash remaining | -29.81 mm | 61.54 mm | 24.58 mm | 33.87 mm | 35.13 mm | 43.14 mm |
| Runway (months of cash) | -1.2 | 13.8 | 1.9 | 3.1 | 3.3 | 4.9 |
| 13F holders | Current |
|---|---|
| Total holders | 152 |
| Opened positions | 21 |
| Closed positions | 22 |
| Increased positions | 59 |
| Reduced positions | 39 |
| 13F shares | Current |
|---|---|
| Total value | 637.81 bn |
| Total shares | 143.06 mm |
| Total puts | 158.70 k |
| Total calls | 178.20 k |
| Total put/call ratio | 0.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Biotechnology Value Fund L P | 9.03 mm | $68.07 mm |
| FMR | 8.56 mm | $50.69 bn |
| Bain Capital Life Sciences Investors | 8.45 mm | $50.02 bn |
| BlackRock | 7.65 mm | $45.27 bn |
| Satter Management | 7.41 mm | $43.84 bn |
| BVF | 7.00 mm | $41.44 bn |
| Redmile | 6.43 mm | $38.05 bn |
| Bain Capital Life Sciences Fund | 5.97 mm | $45.05 mm |
| Point72 Asset Management | 5.33 mm | $31.54 bn |
| BBBOF BB Biotech | 5.16 mm | $38.89 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 9 Jan 25 | William A Jones JR | Stock Option Common Stock | Grant | Acquire A | No | No | 4.83 | 88,000 | 425.04 k | 88,000 |
| 6 Jan 25 | Douglas Love | Common Stock | Option exercise | Acquire M | No | No | 1.4096 | 37,994 | 53.56 k | 356,575 |
| 6 Jan 25 | Douglas Love | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.4096 | 37,994 | 53.56 k | 0 |
| 2 Dec 24 | William H. Carson | Common Stock | Buy | Acquire P | No | Yes | 5.33 | 3,200 | 17.06 k | 25,600 |
| 30 Oct 24 | Douglas Love | Common Stock | Option exercise | Acquire M | No | No | 1.8501 | 36,050 | 66.70 k | 310,570 |
| 30 Oct 24 | Douglas Love | Common Stock | Option exercise | Acquire M | No | No | 1.8501 | 78,399 | 145.05 k | 274,520 |
| 30 Oct 24 | Douglas Love | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.8501 | 36,050 | 66.70 k | 0 |
| 30 Oct 24 | Douglas Love | Stock Option Common Stock | Option exercise | Dispose M | No | No | 1.8501 | 78,399 | 145.05 k | 0 |
